XML 31 R66.htm IDEA: XBRL DOCUMENT v3.19.3
Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Earnings Per Share, Basic and Diluted [Line Items]        
Antidilutive securities excluded from computation of EPS (in shares) 18 12 19 14
Numerator for earnings (loss) per share calculation:        
Income (loss) from continuing operations $ 1,529 $ 1,390 $ 4,887 $ (174)
Income from continuing operations allocated to participating securities 0 (1) (3) (3)
Net loss attributable to noncontrolling interests 1 0 0 0
Income (loss) from continuing operations attributable to CVS Health $ 1,530 $ 1,389 $ 4,884 $ (177)
Denominator for earnings (loss) per share calculation:        
Weighted average shares, basic (in shares) 1,302 1,020 1,300 1,018
Effect of dilutive securities (in shares) 3 2 3 0
Weighted average shares, diluted (in shares) 1,305 1,022 1,303 1,018
Earnings (loss) per share from continuing operations:        
Basic (in dollars per share) $ 1.17 $ 1.36 $ 3.76 $ (0.17)
Diluted (in dollars per share) $ 1.17 $ 1.36 $ 3.75 $ (0.17)
Continuing Operations        
Earnings Per Share, Basic and Diluted [Line Items]        
Antidilutive securities excluded from computation of EPS (in shares)       2